• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.

作者信息

Timmermans Sjoerd A M E G, Ayalon Rivka, van Paassen Pieter, Beck Laurence H, van Rie Henk, Wirtz Joris J J M, Verseput Gaico H, Frenken Leon A, Salant David J, Cohen Tervaert Jan Willem

机构信息

Maastricht University Medical Center, Maastricht, the Netherlands.

出版信息

Am J Kidney Dis. 2013 Dec;62(6):1223-5. doi: 10.1053/j.ajkd.2013.07.019. Epub 2013 Sep 8.

DOI:10.1053/j.ajkd.2013.07.019
PMID:24021909
Abstract
摘要

相似文献

1
Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.抗磷脂酶A2受体抗体与膜性肾病中的恶性肿瘤
Am J Kidney Dis. 2013 Dec;62(6):1223-5. doi: 10.1053/j.ajkd.2013.07.019. Epub 2013 Sep 8.
2
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?膜性肾病中的抗磷脂酶A₂受体抗体：准备好用于常规临床实践了吗？
Neth J Med. 2012 Apr;70(3):109-13.
3
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.原发性膜性肾病中人 M 型磷脂酶 A2 受体自身抗体的酶联免疫吸附测定法的建立。
Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.
4
Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens.两种不同免疫抑制方案治疗的特发性膜性肾病患者中M型磷脂酶A2受体抗体滴度动态变化的预后价值
Biomarkers. 2015 Feb;20(1):77-83. doi: 10.3109/1354750X.2014.993708. Epub 2014 Dec 18.
5
[Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].[特发性膜性肾病新标志物抗磷脂酶A2受体的研究初步结果]
Pol Merkur Lekarski. 2014 Mar;36(213):171-4.
6
[Membranous glomerulonephritis: better therapy with autoantibody monitoring?].[膜性肾小球肾炎：通过自身抗体监测实现更好的治疗？]
Dtsch Med Wochenschr. 2011 Aug;136(34-35):1733-7. doi: 10.1055/s-0031-1286067. Epub 2011 Aug 29.
7
Membranous nephropathy and malignancy.膜性肾病与恶性肿瘤。
Semin Nephrol. 2010 Nov;30(6):635-44. doi: 10.1016/j.semnephrol.2010.09.011.
8
Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.抗磷脂酶A2受体抗体水平可预测膜性肾病移植后复发风险。
Transplantation. 2015 Aug;99(8):1709-14. doi: 10.1097/TP.0000000000000630.
9
Role of anti-phospholipase A(2) receptor antibodies in the differential diagnosis of diabetic and membranous nephropathy.抗磷脂酶A(2)受体抗体在糖尿病肾病与膜性肾病鉴别诊断中的作用
Diabetes Care. 2013 Aug;36(8):e114-5. doi: 10.2337/dc13-0507.
10
Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。
J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.

引用本文的文献

1
Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.THSD7A 相关性膜性肾病中恶性肿瘤的患病率和预后：系统文献复习和临床病例研究。
Ren Fail. 2024 Dec;46(1):2355353. doi: 10.1080/0886022X.2024.2355353. Epub 2024 May 24.
2
Specific antigens in malignancy-associated membranous nephropathy.恶性肿瘤相关性膜性肾病中的特异性抗原
Front Med (Lausanne). 2024 Apr 15;11:1368457. doi: 10.3389/fmed.2024.1368457. eCollection 2024.
3
Malignancy-associated membranous nephropathy: focus on diagnosis and treatment.
恶性肿瘤相关膜性肾病：聚焦于诊断与治疗
J Nephrol. 2023 Nov;36(8):2355-2363. doi: 10.1007/s40620-023-01751-4. Epub 2023 Sep 15.
4
Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia.阿卡替尼治疗与慢性淋巴细胞白血病相关的膜性肾病
Kidney Int Rep. 2022 Sep 12;7(11):2539-2540. doi: 10.1016/j.ekir.2022.09.004. eCollection 2022 Nov.
5
Lung cancer patients with nephropathy as the first manifestation: Literature review and clinical study report.以肾病为首发表现的肺癌患者：文献综述与临床研究报告
Front Oncol. 2022 Sep 29;12:1002155. doi: 10.3389/fonc.2022.1002155. eCollection 2022.
6
Membranous Nephropathy: From Research Bench to Personalized Care.膜性肾病：从研究台到个性化医疗
J Clin Med. 2021 Mar 14;10(6):1205. doi: 10.3390/jcm10061205.
7
Relapse of membranous nephropathy with cancer immunotherapy.癌症免疫疗法导致的膜性肾病复发
Clin Kidney J. 2019 Jun 21;14(1):418-420. doi: 10.1093/ckj/sfz074. eCollection 2021 Jan.
8
Secondary Membranous Nephropathy. A Narrative Review.继发性膜性肾病。一篇综述。
Front Med (Lausanne). 2020 Dec 3;7:611317. doi: 10.3389/fmed.2020.611317. eCollection 2020.
9
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab.免疫检查点抑制剂相关原发性膜性肾病激活，对利妥昔单抗治疗有反应。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001287.
10
The investigative burden of membranous nephropathy in the UK.英国膜性肾病的调查负担
Clin Kidney J. 2019 Apr 23;13(1):27-34. doi: 10.1093/ckj/sfz036. eCollection 2020 Feb.